{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=61&state=Kentucky", "query": { "state": "Kentucky", "city": "Louisville", "page": 61 }, "page_size": 10 }, "pagination": { "page": 61, "page_size": 10, "total_count": 5305, "total_pages": 531, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=62&state=Kentucky&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=60&state=Kentucky&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T12:04:21.020Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06616974", "title": "A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Hypertension", "Heart Failure With Preserved Ejection Fraction" ], "interventions": [ { "name": "TX000045- Dose A", "type": "DRUG" }, { "name": "TX000045- Dose B", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tectonic Therapeutic", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "83 Years", "sex": "ALL", "summary": "18 Years to 83 Years" }, "enrollment_count": 191, "start_date": "2024-09-04", "completion_date": "2027-01-05", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • San Francisco, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06616974" }, { "nct_id": "NCT04662710", "title": "Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced/Metastatic Gastroesophageal Adenocarcinoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Lenvatinib", "type": "BIOLOGICAL" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Leucovorin (or Levoleucovorin)", "type": "DRUG" }, { "name": "5-FU", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 895, "start_date": "2020-12-30", "completion_date": "2026-03-30", "has_results": true, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 12, "location_summary": "Los Angeles, California • Washington D.C., District of Columbia • Louisville, Kentucky + 8 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04662710" }, { "nct_id": "NCT03869190", "title": "Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Urothelial Carcinoma", "Bladder Cancer" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Enfortumab Vedotin", "type": "DRUG" }, { "name": "Niraparib", "type": "DRUG" }, { "name": "Magrolimab (Hu5F9-G4)", "type": "DRUG" }, { "name": "Tiragolumab", "type": "DRUG" }, { "name": "Sacituzumab Govitecan", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 272, "start_date": "2019-06-01", "completion_date": "2025-12-22", "has_results": true, "last_update_posted_date": "2026-08-03", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Stanford, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03869190" }, { "nct_id": "NCT00017160", "title": "Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stage III Adult Soft Tissue Sarcoma", "Recurrent Adult Soft Tissue Sarcoma", "Stage IVA Adult Soft Tissue Sarcoma", "Stage IIB Adult Soft Tissue Sarcoma", "Stage IIC Adult Soft Tissue Sarcoma" ], "interventions": [ { "name": "doxorubicin", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "biological response modifier therapy", "type": "PROCEDURE" }, { "name": "brachytherapy", "type": "PROCEDURE" }, { "name": "chemotherapy", "type": "PROCEDURE" }, { "name": "colony-stimulating factor therapy", "type": "PROCEDURE" }, { "name": "conventional surgery", "type": "PROCEDURE" }, { "name": "cytokine therapy", "type": "PROCEDURE" }, { "name": "intraoperative radiotherapy", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "PROCEDURE" }, { "name": "surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2013-06-27", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 216, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 165 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00017160" }, { "nct_id": "NCT02242760", "title": "P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "SB204 2%", "type": "DRUG" }, { "name": "SB204 4%", "type": "DRUG" }, { "name": "Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novan, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 213, "start_date": "2014-11", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2023-05-31", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 20, "location_summary": "Hot Springs, Arkansas • Encinitas, California • San Diego, California + 15 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02242760" }, { "nct_id": "NCT00277524", "title": "OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tachycardia, Ventricular", "Heart Failure, Congestive", "Ventricular Fibrillation", "Ventricular Dysfunction", "Bradycardia" ], "interventions": [], "intervention_types": [], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3032, "start_date": "2005-08", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2013-08-28", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 113, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Fresno, California + 107 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277524" }, { "nct_id": "NCT04232696", "title": "Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urinary Urgency Incontinence" ], "interventions": [ { "name": "Neuspera Implantable Sacral Nerve Stimulation System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Neuspera Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 331, "start_date": "2019-12-13", "completion_date": "2026-12", "has_results": true, "last_update_posted_date": "2025-11-03", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 31, "location_summary": "Encinitas, California • Los Angeles, California • San Diego, California + 27 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Pompano Beach", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04232696" }, { "nct_id": "NCT01594983", "title": "A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Familial Chylocmicronemia Syndrome (Non-FCS)" ], "interventions": [ { "name": "LCQ908", "type": "DRUG" }, { "name": "Fenofibrate", "type": "DRUG" }, { "name": "Fish Oil", "type": "DRUG" }, { "name": "Placebo of LCQ908", "type": "DRUG" }, { "name": "Placebo of fenofibrate", "type": "DRUG" }, { "name": "Placebo of fish oil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2012-06", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 28, "location_summary": "Muscle Shoals, Alabama • Glendale, Arizona • Encinitas, California + 23 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01594983" }, { "nct_id": "NCT06678841", "title": "ELEVATE-HFpEF Clinical Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure With Preserved Ejection Fraction (HFpEF)" ], "interventions": [ { "name": "Personalized cardiac pacing", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 700, "start_date": "2025-07-09", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Palo Alto, California • San Francisco, California + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Panama City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06678841" }, { "nct_id": "NCT00044759", "title": "Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hematologic Neoplasms" ], "interventions": [ { "name": "Piperacillin/Tazobactam (Tazocin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": "2003-01", "has_results": false, "last_update_posted_date": "2007-10-10", "last_synced_at": "2026-11-04T12:04:21.020Z", "location_count": 31, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Denver, Colorado + 25 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "North Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044759" } ] }